Growing a community for health research translation at York

Lead Research Organisation: University of York
Department Name: UNLISTED

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Technical Summary

The Confidence in Concept scheme is a key part of MRC’s translational research strategy and provides annual awards to institutions, to be used flexibly to support the earliest stages of multiple translational research projects. The award can be used by the institution to support a number of preliminary-stage translational projects. The projects supported should aim to provide sufficient preliminary data to establish the viability of an approach –– before seeking more substantive funding.  It is intended to accelerate the transition from discovery research to translational development projects by supporting preliminary work or feasibility studies to establish the viability of an approach.

Publications

10 25 50
 
Description Call 2 - UKRI CoA Extension to R18884 - Challenging Dogma: an alternative non-hierarchical, epigenetically regulated model of the urothelium
Amount £82,574 (GBP)
Funding ID EP/V520561/1 
Organisation Economic and Social Research Council 
Sector Public
Country United Kingdom
Start 05/2021 
End 09/2021
 
Description Challenging dogma: an alternative non-hierarchical, epigenetically regulated model of the urothelium.
Amount £453,910 (GBP)
Funding ID BB/R006172/1 
Organisation Biotechnology and Biological Sciences Research Council (BBSRC) 
Sector Public
Country United Kingdom
Start 05/2018 
End 04/2022
 
Description Combating depression with non-invasive modification of REM-sleep brain activity
Amount £30,000 (GBP)
Organisation Grow MedTech 
Sector Academic/University
Country United Kingdom
Start 10/2019 
End 09/2020
 
Description Development of a novel human biomaterial HABM (Human Acellular Bladder Matrix) for surgical applications
Amount £20,006 (GBP)
Organisation Grow MedTech 
Sector Academic/University
Country United Kingdom
Start 01/2019 
End 03/2022
 
Description Effect of cancer-associated CIZ1 fragments on CIZ1 function in maintenance of epigenetic landscape
Amount £54,136 (GBP)
Organisation The Royal Society 
Sector Charity/Non Profit
Country United Kingdom
Start 10/2019 
End 09/2020
 
Description HABM: a natural regenerative biomaterial for surgical use
Amount £34,977 (GBP)
Organisation Biotechnology and Biological Sciences Research Council (BBSRC) 
Sector Public
Country United Kingdom
Start 12/2019 
End 03/2022
 
Description High-fidelity epigenetic maintenance in somatic cells: CIZ1 assemblies as molecular shield
Amount £492,427 (GBP)
Funding ID MR/V029088/1 
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 08/2021 
End 08/2025
 
Description Partnership Award with Barts Cancer Institute
Amount £11,522 (GBP)
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 09/2017 
End 08/2019
 
Description Role of CIZ1 in maintenance of epigenetic landscape in primary differentiated cells
Amount £407,860 (GBP)
Funding ID MR/R008981/1 
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 04/2018 
End 06/2022
 
Description Transplantation urology: scoping new sources and applications for a natural acellular bladder biomaterial
Amount £27,990 (GBP)
Organisation Grow MedTech 
Sector Academic/University
Country United Kingdom
Start 05/2019 
End 01/2020
 
Description Understanding how unwanted memories persist: The role of sleep spindles in emotional memory consolidation
Amount £40,000 (GBP)
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 03/2019 
End 09/2019
 
Description White Rose BBSRC DTP studentship 2019 - 2022 - Alina Capatina
Amount £97,344 (GBP)
Organisation Biotechnology and Biological Sciences Research Council (BBSRC) 
Sector Public
Country United Kingdom
Start 10/2019 
End 09/2023
 
Description Sleep and emotional regulation in forensic mental health settings: Partnership with NHS Mental Health Foundation Trust 
Organisation Tees, Esk and Wear Valleys NHS Foundation Trust
Country United Kingdom 
Sector Public 
PI Contribution An event took place on 23rd January 2019 involving talks on sleep from academics, including Dr. Scott Cairney, and specialists working in forensic and clinical settings (including secure units).
Collaborator Contribution The event included talks on sleep from clinical/forensic leads within the Tees, Esk and Wear Valleys (TEWV) NHS Foundation Trust.
Impact Collaboration has been ongoing since the event with exploration of the potential to use NIHR Research Capability Funding (RCF) to develop sleep research capacity in secure units. The collaborators are currently writing up a scoping review.
Start Year 2019
 
Description University of York & Ono Pharmaceuticals 
Organisation Ono Pharmaceutical
Country Japan 
Sector Private 
PI Contribution Three people in the lab carried out defined experiments using our specialist expertise
Collaborator Contribution Financial contribution
Impact Answered the company's questions
Start Year 2017
 
Company Name CIZZLE BIOTECHNOLOGY HOLDINGS PLC 
Description Enabling faster treatment with early lung cancer detection to save lives Cizzle Biotech was initially funded by Yorkshire Cancer Research, White Rose Technology Seed Corn Fund, Finance Yorkshire Seedcorn LLP and Viking Members, who with management, invested in the project to support the development of a prototype blood test. 
Year Established 2007 
Impact Cizzle Biotech has gained patent protection for its core technology and has developed a laboratory Cizzle have been listed on the London Stock Exchange
Website https://cizzlebiotechnology.com
 
Description Presentation at "Incontinence: The Engineering Challenge XI" at the Institution of Mechanical Engineers 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Industry/Business
Results and Impact We attended the conference as a key note speaker and presented our research project to an audience of academics and industry contacts. We were able to liaise with pharmaceutical companies at the conference.
Year(s) Of Engagement Activity 2017
URL http://events.imeche.org/ViewEvent?code=CON6475